天弘恒生沪深港创新药精选50ETF发起联接C(014565)资产配置 |
|
|
| 报告日期 |
股票(元) |
债券(元) |
基金总资产(元) |
基金净值(元) |
股票占净值比 |
| 2025/9/30 |
22,522,200 |
- |
796,710,000 |
730,292,000 |
3% |
| 2025/6/30 |
11,455,100 |
1,004,410 |
315,523,000 |
289,876,000 |
4% |
| 2025/3/31 |
4,970,100 |
301,733 |
223,050,000 |
219,772,000 |
2% |
| 2024/12/31 |
1,360,990 |
101,263 |
66,577,700 |
65,774,900 |
2% |
| 2024/9/30 |
3,043,160 |
201,565 |
78,223,500 |
75,057,700 |
4% |
| 2024/6/30 |
1,859,430 |
407,276 |
61,897,100 |
60,367,800 |
3% |
| 2024/3/31 |
2,064,330 |
- |
67,513,800 |
65,002,800 |
3% |
| 2023/12/31 |
2,442,390 |
101,523 |
89,032,000 |
87,359,900 |
3% |
| 2023/9/30 |
1,747,920 |
- |
66,818,900 |
63,996,800 |
3% |
| 2023/6/30 |
1,769,290 |
101,110 |
47,847,800 |
46,647,300 |
4% |
| 2023/3/31 |
770,075 |
- |
34,935,400 |
32,438,400 |
2% |
| 2022/12/31 |
439,877 |
101,284 |
26,012,900 |
24,459,500 |
2% |
| 2022/9/30 |
242,927 |
- |
20,665,800 |
20,216,700 |
1% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。